2021 BIOPACIFIC CONFERENCE

Theme: Passion for Better Medicine

Virtual Zoom Conference

8:30 AM – 8:50 AM Breakout Room Networking
8:50 AM 8:55 AM Welcome Remarks
Carrie Wang, MD, President-elect of CABS and 2021 BioPacific Conference Organizing Committee Chair
8:55 AM 9:00 AM State of the Society
Yan Wang, PhD, President of CABS
9:00 AM 9:35 AM Keynote #1: Traffic of Cas9-gRNA Between Cultured Human Cells Mediated by Cell-Cell Contact Randy Schekman, PhD, Professor, Department of Molecular and Cell Biology, UC Berkeley
2013 Nobel Prize for Physiology or Medicine
9:35 AM 10:00 AM CABS K. Fong Award in Life Sciences
Presenter: Kenneth Fong, PhD, Chairman, Kenson Ventures
Awardees: John O. Link, PhD, Former VP, Gilead (Retired 2020)
Xianping Lu, PhD, Founder, Chairman and CEO, ChipScreen BioSciences
10:00 AM10:25 AM K. Fong Award Speech: Reshaping Biotech Landscape in China
Xianping Lu, PhD, Founder, Chairman and CEO, ChipScreen BioSciences
10:25 AM 10:50 AM Enoxaparin: A Twice-Yearly Dosed First-in-Class HIV Capsid Inhibitor
John O. Link, PhD , Former VP, Gilead (Retired 2020)
10:50 AM 11:20 AM Cancer Immunotherapy Trends and Highlights in the Post-Checkpoint Inhibitor Approval Era

Gary Starling, PhD, CSO, Xyphos-Astellas Pharma Inc

11:20 AM 12:00 PM Panel Discussion 1: IP Considerations and Investment trends for Life Sciences
This session will cover intellectual property considerations for life science transactions and stories of investment in new technologies. Options to structure a new company will be discussed.
Moderator: Janet Xiao, PhD, JD, Partner, Head of MoFo’s China Life Sciences, Morrison & Foerster LLP
Panelists:Chuck Comey, Partner, Morrison & Foerster LLP
Sean Cao, PhD, MBA, Managing Director, the CBC Group
Neil Desai, PhD, Founder & CEO, AADI
12:00 PM 12:30 PM

Breakout room talks
Room 1:
Effective Use of Science in the FDA Regulatory Process
Bethany Hills, PhD, Partner, Morrison & Foerster LLP
Keunbong (KB) Do, Associate, Morrison & Foerster LLP

Room 2:
Precise and Efficient Non-viral CRISPR Gene Editing Solutions
Lumeng Ye, PhD, Sr. Scientist, GenScript USA Inc

Room 3:
Humanized models for improved preclinical discovery and assessment of novel immunotherapies
Jenna Frame, PhD, Manager, Scientific Communications & Marketing, Biocytogen Boston

Room 4:
Atomic-resolution cryoEM and its impact on SBDD
Larry Jin, PhD, COO, Wuxi Biortus Biosciences Ltd.
What’s Ahead for the Biotech Industry: Another Wave or Low Tide?
Michael Zhao, Co-founder, Q Bay (Boston)

Room 5:
Clinical Study in the US and China
Charles Li, MS MBA, VP, Business Development, CR Medicon.

Afternoon Session
12:30 PM 1:05 PM Keynote #2: Towards Universal Druggability
Gregory L. Verdine, PhD, Professor, Chemical Biology, Harvard
1:05 PM – 1:35 PM How we Use Stem Cells & Genomics for Guiding Precision Medicine
Joseph Wu, MD, PhD, Director of Stanford Cardiovascular Institute and Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University.
1:35 PM – 2:05 PM Designing Better Molecules Faster and with Less Expense: Illustrations of the Transformative
Impact of Physics-Based Modeling Combined with Machine Learning

Matt Repasky, PhD,
SVP, Life Sciences Products, Schrodinger Inc (Boston)
2:05 PM – 2:35 PM The COVID-19 Pandemic: A Status Report
Arthur Reingold,, Professor and Head of the Division of Epidemiology at the School of Public Health, UC Berkeley
2:35 PM 3:15PM Panel Discussion 2: Strategic Partnerships & Financing Trends for the Biotech Industry
Moderator: Cheni Kwok, PhD, CLP, Managing Partner & Founder
Panelists: Edward, Harrington, MBA, CFO of Genentech
Guo-Liang Yu, PhD, CEO, Apollomics
Dewan Zeng, PhD, Executive Director of BeiGene
Chen Yu, MD, MBA, Founder and Managing Partner, TCG
3:15 PM 3:45 PM FDA Experience and Regulatory Considerations on Companion Diagnostics and Cancer Early Detection Test
Sharon Liang, MD, PhD , RVC, VP, Regulatory Affairs and Quality Affairs, Burning Rock Dx.
3:45 PM 4:00 PM A World-Class Healthcare Technology Innovation Platform at Hong Kong Science Park
Carrie Ling, PhD, Assistant Director of Business Development (InnoHK) HKSTP
4:00 PM – 4:05 PM – Conference Adjourned
4:05 PM – 4:30 PM – Breakroom Networking